Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4DC
|
||||
Former ID |
DAP001236
|
||||
Drug Name |
Butenafine
|
||||
Synonyms |
Butenafina; Butenafinum; Mentax; Butenafine HCL; Butenafine [INN]; Butenafine hydrochloride; KP 363; Butenafina [INN-Spanish]; Butenafine (INN); Butenafinum [INN-Latin]; Butop (TN); KP-363; Mentax (TN); N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride; N-p-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine; N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine; 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine; 4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Dermatologic infections [ICD9: 680-686; ICD10:L00-L08] | Approved | [536361] | ||
Therapeutic Class |
Antifungal Agents
|
||||
Company |
Schering-Plough
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H27N
|
||||
Canonical SMILES |
CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32
|
||||
InChI |
1S/C23H27N/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20/h5-15H,16-17H2,1-4H3
|
||||
InChIKey |
ABJKWBDEJIDSJZ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 101828-21-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10267, 603409, 5615389, 8151659, 11342191, 11362374, 11364447, 11367009, 11369571, 11377733, 11487776, 11495367, 14874583, 29215487, 29215488, 29221648, 46506191, 50064067, 51091907, 56313731, 57321348, 79503477, 81040926, 89736078, 92308960, 92712424, 92729938, 93166394, 103261258, 104300725, 124766539, 125336650, 126630107, 126683136, 127381627, 134338475, 135023666, 137006422, 142244396, 144205282, 152034324, 160964425, 162177723, 162201865, 163123303, 164814813, 170465093, 175268882, 175449030, 176484075
|
||||
SuperDrug ATC ID |
D01AE23
|
||||
SuperDrug CAS ID |
cas=101828211
|
||||
Target and Pathway | |||||
Target(s) | Fungal squalene epoxidase | Target Info | Modulator | [556264] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.